Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,162 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

NCT02108639

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Clinical Pharmacology Of Miami Inc. Miami, Florida, United States
  • Orlando Clinical Research Center Orlando, Florida, United States
  • Davita Clinical Research Minneapolis, Minnesota, United States
  • New Orleans Center For Clinical Research - Knoxville Knoxville, Tennessee, United States
View Trial Details
Completed

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

NCT00144170

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1182.48.5401 Fundación Huésped Buenos Aires, Argentina
  • 1182.48.5402 Fundación Huésped Buenos Aires, Argentina
  • 1182.48.5403 Servicio de Infecciosas Buenos Aires, Argentina
  • 1182.48.5404 Servicio de Infecciosas Buenos Aires, Argentina
View all 174 locations
View Trial Details
Completed

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

NCT00054717

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1182.12.62 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 1182.12.108 El Rio SIA Tucson, Arizona, United States
  • 1182.12.9 Boehringer Ingelheim Investigational Site Berkeley, California, United States
  • 1182.12.23 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
View all 117 locations
View Trial Details
Completed

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

NCT00979420

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site 1 Aachen, Germany
  • Boehringer Ingelheim Investigational Site 10 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 11 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 12 Berlin, Germany
View all 60 locations
View Trial Details
Completed

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

NCT00606086

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Scripps Clinic Torrey Pines La Jolla, California, United States
  • Research and Education inc. San Diego, California, United States
View all 25 locations
View Trial Details
Completed

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

NCT00110305

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Beverly Hills, California, United States
  • Washington D.C., District of Columbia, United States
  • Orlando, Florida, United States
  • Tampa, Florida, United States
View all 40 locations
View Trial Details

Related conditions